Welcome to LookChem.com Sign In|Join Free

CAS

  • or

151602-46-9

Post Buying Request

151602-46-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[4-(1-oxohexyl)-1-piperazinyl]-

    Cas No: 151602-46-9

  • No Data

  • No Data

  • No Data

  • Atomic chemistry
  • Contact Supplier

151602-46-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 151602-46-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,6,0 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 151602-46:
(8*1)+(7*5)+(6*1)+(5*6)+(4*0)+(3*2)+(2*4)+(1*6)=99
99 % 10 = 9
So 151602-46-9 is a valid CAS Registry Number.

151602-46-9Downstream Products

151602-46-9Relevant articles and documents

Studies on the antimicrobial properties of N-acylated ciprofloxacins

Cormier, Ryan,Burda, Whittney N.,Harrington, Lacey,Edlinger, Jordan,Kodigepalli, Karthik M.,Thomas, John,Kapolka, Rebecca,Roma, Glen,Anderson, Burt E.,Turos, Edward,Shaw, Lindsey N.

, p. 6513 - 6520 (2012)

Fluoroquinolone antibiotics have been a mainstay in the treatment of bacterial diseases. The most notable representative, ciprofloxacin, possesses potent antimicrobial activity; however, a rise in resistance to this agent necessitates development of novel derivatives to prolong the clinical lifespan of these antibiotics. Herein we have synthesized and analyzed the antimicrobial properties of a library of N-acylated ciprofloxacin analogues. We find that these compounds are broadly effective against Gram-positive and Gram-negative bacteria, with many proving more effective than the parental drug, and several possessing MICs ≤1.0 μg/ml against methicillin-resistant Staphylococcus aureus and Bartonella species. An analysis of spontaneous mutation frequencies reveals very low potential for resistance in MRSA compared to existing fluoroquinolones. Mode of action profiling reveals that modification of the piperazinyl nitrogen by acylation does not alter the effect of these molecules towards their bacterial target. We also present evidence that these N-acylated compounds are highly effective at killing intracellular bacteria, suggesting the suitability of these antibiotics for therapeutic treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 151602-46-9